Endo, Arnold & Porter Split Amid Opioid Litigation Troubles
By Jeff Overley · October 29, 2021, 7:33 PM EDT
Amid a major controversy over discovery shortcomings, Endo Pharmaceuticals disclosed late Friday that Arnold & Porter is departing as its counsel in multidistrict opioid litigation and being replaced by Skadden....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login